Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418701 · ClinicalTrials.gov registry record · NA
Health-Smart for Weight Loss at UF Jax Clinics
A NA study of Obesity, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 683
- Enrollment target
- 1
- Study location
NCT03418701: Completed NA study of Obesity, sponsored by University of Florida.
NCT03418701 is a NA study of Obesity that has completed, run by University of Florida. The registered enrollment target is 683 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03418701, a NA study of Obesity, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 683 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test the effectiveness of a culturally sensitive, evidence-based, multi-component, behavioral program for treating obesity called Health-Smart. This program is being implemented by Community Health Workers at the primary care centers and followed by either of two physician-implemented behavioral counseling programs to prevent weight gain--programs that are implemented quarterly over 12 months.
Primary Outcome
percentage of participating patients who show clinically significant weight loss (i.e., at least 5% of baseline body weight)
Conditions Studied
Interventions
- BEHAVIORAL Health Smart for Weight Loss
Study Locations (1)
Florida
- UF Health Jacksonville Primary Care network - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 683 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT03418701 record still lists
NCT03418701 is an interventional study that assigns participants to a tested intervention. The registered 683 participants enrollment target is mid-sized for trials with a published cap, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Health Smart for Weight Loss is the first listed.
NCT03418701 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03418701 about?
NCT03418701 is a clinical study titled "Health-Smart for Weight Loss at UF Jax Clinics". The study will test the effectiveness of a culturally sensitive, evidence-based, multi-component, behavioral program for treating obesity called Health-Smart. This program is being implemented by Community Health Workers at the primary care centers and followed by either of two physician-implemented...
What is the current status of trial NCT03418701?
This trial is currently completed. It is a NA study. The enrollment target is 683 participants. The study started on 2018-04-01. Estimated completion is 2022-07-31.
What conditions does trial NCT03418701 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT03418701?
The interventions under investigation include: Health Smart for Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT03418701?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03418701 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03418701's enrollment target sits among peer trials
683 109th of 1053 higher than 945 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI